Simultaneous dual coronary very late stent thrombosis following noncardiac surgery

Shailja V Parikh1, Ashish Parikh, Emmanouil S Brilakis

  • 1Division of Cardiovascular Diseases, VA North Texas Healthcare System, University of Texas Southwestern Medical Center, Dallas, TX 75216, USA.

Insights

Patients with drug-eluting stents (DES) face risks during noncardiac surgery. Discontinuing antiplatelet therapy for surgery can lead to dangerous stent thrombosis, even years after DES placement.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Managing patients with drug-eluting stents (DES) undergoing noncardiac surgery presents a clinical dilemma.
  • Balancing the risk of surgical bleeding against the risk of stent thrombosis from interrupted dual antiplatelet therapy is critical.

Observation:

  • A case report details a patient who experienced simultaneous stent thrombosis in two coronary arteries.
  • This event occurred after clopidogrel discontinuation for an elective noncardiac surgery.

Findings:

  • The patient had drug-eluting stents placed 3 years prior to the noncardiac surgery.
  • Discontinuation of dual antiplatelet therapy, specifically clopidogrel, preceded the thrombotic event.

Implications:

  • This case highlights the potential for late stent thrombosis in patients with DES, even years after implantation.
  • Careful consideration of antiplatelet therapy management is crucial for patients with DES undergoing noncardiac procedures.
  • Further research into optimal perioperative management strategies for these patients is warranted.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...